Phase 2 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been officially diagnosed with systemic lupus erythematosus (a condition where the immune system attacks the body's own tissues)
- Your lupus disease activity score (a standard measure called SLEDAI-2K) is 6 or higher, meaning your condition is considered at least moderately active
- You are willing and able to sign a consent form and follow the requirements of the study
- You have already been taking appropriate doses of steroids, antimalarial drugs, or immune-suppressing medications for at least 3 months
Who may not be able to join:
- You have an unstable short-term or long-term illness that is not well controlled
- You currently have an active infection of any kind
- You have been diagnosed with cancer at any point in the last 5 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 021-50805989-08324
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
incidence of adverse event
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.